Status:
COMPLETED
Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation
Lead Sponsor:
University of Florida
Collaborating Sponsors:
Department of Health and Human Services
National Institute on Aging (NIA)
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
60-89 years
Phase:
NA
Brief Summary
Patients with amnestic mild cognitive impairment (MCI) often have compromised quality of life (QOL). Cognitive impairment is a major contributor to decrements in QOL and progression of MCI often leads...
Detailed Description
Patients with amnestic mild cognitive impairment (MCI) often have compromised quality of life (QOL). Cognitive impairment is a major contributor to decrements in QOL and progression of MCI often leads...
Eligibility Criteria
Inclusion
- Diagnosed with amnestic mild cognitive impairment/mild Alzheimer's disease
- Preservation of independence in functional abilities
- Healthy aged adults without MCI to serve as control group
Exclusion
- Other medical or neurological conditions that may be associated with significant impaired cognition (e..g, moderate to severe traumatic brain injury, epilepsy, etc...)
- Vascular dementia or other non-AD spectrum diagnosed neurodegenerative disorders
- Significant current depression
- Uncorrected vision/hearing loss
- Unable to undergo MRI exam
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT03359902
Start Date
January 1 2018
End Date
May 31 2022
Last Update
October 24 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Malcom Randall VA Medical Center
Gainesville, Florida, United States, 32608
2
McKnight Brain Institute
Gainesville, Florida, United States, 32608
3
University of Florida
Gainesville, Florida, United States, 32610